ACE inhibitors &ndash; angiotensin II receptor antagonists: A useful combination therapy for ischemic heart disease

ACE inhibitors &ndash; angiotensin II receptor antagonists: A useful combination therapy for ischemic heart disease

T S Mohamed Saleem1, K Bharani1, K Gauthaman21Department of Pharmacology, Annamacharya College of Pharmacy, Rajampet-516126, Kadapa Dist, Andhra Pradesh, India; 2Department of Drug Technology, Higher Institute of Medical Technology, Derna, LibyaAbstract: Morbidity and mortality from cardiovascular d...

Full description

Bibliographic Details
Main Authors:	T S Mohamed Saleem, K Bharani, K Gauthaman
Format:	Article
Language:	English
Published:	Dove Medical Press 2010-07-01
Series:	Open Access Emergency Medicine
Online Access:	http://www.dovepress.com/ace-inhibitors-ndash-angiotensin-ii-receptor-antagonists-a-useful-comb-a4739

Similar Items

ACE inhibitors, angiotensin receptor antagonists and bradykinin
by: Michael Schachter
Published: (2000-03-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES
by: E. M. Khurs, et al.
Published: (2016-01-01)

Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure.
by: Andrea Kuenzli, et al.
Published: (2010-04-01)

Combination is better than monotherapy with ACE inhibitor or angiotensin receptor antagonist at recommended doses
by: Julián Segura, et al.
Published: (2003-03-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
by: M. L. Maksimov, et al.
Published: (2010-04-01)

Interaction of -blockers and angiotensin receptor blockers/ACE inhibitors in heart failure
by: Jay N Cohn
Published: (2003-09-01)

Angiotensin II receptor antagonist and ACE inhibitor effectiveness in cognitive function correction among elderly patients with arterial hypertension
by: S. V. Nedogoda, et al.
Published: (2007-06-01)

ACE inhibitor and angiotensin receptor-II antagonist prescribing and hospital admissions with acute kidney injury: a longitudinal ecological study.
by: Laurie A Tomlinson, et al.
Published: (2013-01-01)

RU28318, an Aldosterone Antagonist, in Combination with an ACE Inhibitor and Angiotensin Receptor Blocker Attenuates Cardiac Dysfunction in Diabetes
by: Ibrahim F. Benter, et al.
Published: (2013-01-01)

EFFECT OF ACE INHIBITOR AND RECEPTOR ANTAGONIST OF TYPE 1 ANGIOTENSIN II ON HEMODYNAMICS AND MORPHO-FUNCTIONAL PARAMETERS OF THE HEART IN PATIENTS WITH HEART FAILURE ON A BACKGROUND OF CORONARY HEART DISEASE COMBINED WITH TYPE 2 DIABETES
by: Z. V. BITAROVA, et al.
Published: (2017-09-01)

Metabolic syndrome and angiotensin II receptor antagonists
by: K. M. Mamyrbayeva, et al.
Published: (2007-04-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND PROTEINURIA
by: Tanja Kök, et al.
Published: (2002-03-01)

Arterial hypertension and coronary heart disease: the place of angiotensin II receptor antagonists
by: E. O. Taratukhin
Published: (2012-12-01)

Comparing recommended doses of angiotensin receptor blockers and ACE inhibitors (CORD Study)
by: J. Spinar, et al.
Published: (2009-08-01)

Review: Effect of combining angiotensin receptor blockers and ACE inhibitors on cardiovascular disease
by: Trefor Morgan
Published: (2001-03-01)

Eprosartan mesylate, an angiotensin II receptor antagonist
by: Jing-Jing Qian, et al.
Published: (2011-04-01)

Spectrofluorimetric method for determination of some angiotensin II receptor antagonists
by: Salwa R. El-Shaboury, et al.
Published: (2012-02-01)

Fimasartan, an angiotensin II receptor antagonist, ameliorates an in vivo zebrafish model of heart failure
by: Hailian Quan, et al.
Published: (2020-11-01)

Kidney Function, ACE-Inhibitor/Angiotensin Receptor Blocker Use, and Survival Following Hospitalization for Heart Failure: A Cohort Study
by: Michael H. Chiu, et al.
Published: (2018-10-01)

Debatable points of using angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in patients with COVID-19
by: O. M. Drapkina, et al.
Published: (2020-07-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND NEPHROPROTECTION: PLACE OF OLMESARTAN
by: V. V. Fomin
Published: (2013-08-01)

Ongoing clinical trials with angiotensin II receptor antagonists in chronic heart failure and myocardial infarction
by: John McMurray, et al.
Published: (2000-06-01)

Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function
by: Bo-qing Zhu, et al.
Published: (2003-03-01)

Angiotensin II antagonists
by: David García Barreto, et al.
Published: (2014-03-01)

Studies on the angiotensin converting enzyme gene polymorphism and ACE inhibitors
by: Chadwick, Ian George
Published: (1997)

Perspectives of using angiotensin receptor antagonists
by: V V Fomin
Published: (2009-06-01)

Difficult choice: angiotensin receptor antagonists
by: E. O. Taratukhin
Published: (2013-04-01)

ANGIOTENSIN RECEPTOR ANTAGONISTS: GOING WITH THE TIMES
by: E. O. Taratukhin
Published: (2013-06-01)

Long-Term Consequences of Fetal Angiotensin II Receptor Antagonist Exposure
by: K. Wegleiter, et al.
Published: (2018-01-01)

ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES
by: Y. A. Karpov
Published: (2015-12-01)

ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES
by: Y. A. Karpov
Published: (2015-12-01)

Inhibidores de la enzima conversora de angiotensina y antagonistas de receptores de angiotensina II en insuficiencia cardíaca Angiotensin-converting-enzyme inhibitor and angiotensin II-receptors antagonists in heart failure
by: José Eugenio Negrín Expósito
Published: (2004-02-01)

Effect of long-term therapy with AT1angiotensin II receptor blockers in combination with aldosterone receptor inhibitor on ischemic myocardial remodelling and chronic heart failure
by: AT Teplyakov, et al.
Published: (2014-12-01)

Angiotensin-converting enzyme (ACE) I/D and bradykinin B2 receptor T/C genes polymorphism in patients with ACE inhibitors-related cough
by: Mohammad Saifur Rohman, et al.
Published: (2018-10-01)

ACE inhibitors in patients with heart failure
by: O. P. Shevchenko, et al.
Published: (2008-10-01)

Effect of angiotensin II receptor blockers and calcium antagonists on cognition
by: O. D. Ostroumova, et al.
Published: (2016-12-01)

PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
by: S. A. Boytsov, et al.
Published: (2016-01-01)

Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors
by: Daniel eClayton, et al.
Published: (2015-01-01)

Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients
by: Ikram Omar Osman, et al.
Published: (2021-06-01)

MECHANISMS OF COMBINED ACTION OF ACE INHIBITORS AND CALCIUM ANTAGONISTS IN ARTERIAL HYPERTENSION
by: E. I. Astashkin, et al.
Published: (2013-06-01)